DigniCap Delta Hair Loss Prevention System for Chemo Now in U.S.
Dignitana, a company out of Lund, Sweden, won FDA clearance and is now distributing its DigniCap Delta scalp cooling system in the U.S. The University of California, San Francisco (UCSF) will be the first recipient in America of the fourth generation system that’s designed to prevent hair loss in patients undergoing chemotherapy to fight solid tumors.
The system pumps a cool liquid, carefully controlled thanks to a number of sensors, through a cap worn by patients undergoing chemo. Cooling the head constricts the blood vessels in the scalp, reducing the amount of chemo that can pass through. At the same time, the colder conditions mean that cellular metabolism slows down, further reducing the uptake of chemo into the hair follicles.
The new DigniCap Delta system features a solid state cooling controller to maintain precise temperatures through the treatment process and a much more compact overall design that is nearly half the size of the last model.
Additionally, a more intuitive interface allows clinicians to get on with therapy much quicker and may reduce nursing time by as much as 80 percent, according to Dignitana.